Depression treatment depends on severity, duration, recurrence, risk, previous treatment response, personal preferences and coexisting conditions. Common treatments include psychological therapies, antidepressant medication, behavioural and social interventions, and combinations of these approaches. Mild depression may sometimes be managed initially with guided self-help, structured psychological interventions, physical-activity advice and monitoring, whereas moderate or severe depression may require formal psychological therapy, medication or both. NICE guidance recommends a stepped and personalised approach rather than treating every depressive episode identically. (nice.org.uk)
Psychological therapies are established treatments for depression. Cognitive behavioural therapy, or CBT, helps identify and modify unhelpful patterns of thinking and behaviour while increasing engagement with useful activities. Behavioural activation focuses particularly on reducing withdrawal and gradually increasing meaningful or rewarding activity. Other evidence-based approaches include interpersonal therapy and counselling in appropriate circumstances. Therapy may be delivered individually, in groups, face-to-face or through structured digital formats depending on the treatment and healthcare system. The choice depends on clinical needs, availability and patient preference.
Antidepressants are medications used to treat depressive disorders, with selective serotonin reuptake inhibitors, or SSRIs, among commonly prescribed options. Other antidepressant classes include serotonin-noradrenaline reuptake inhibitors and several other agents with different pharmacological mechanisms. Antidepressants generally do not work immediately; benefits may develop over several weeks, while side effects can occur earlier. They are not considered addictive in the same way as substances such as alcohol or opioids, although stopping some antidepressants abruptly can cause discontinuation symptoms. Treatment should therefore be reviewed and discontinued gradually when clinically appropriate rather than stopped suddenly without advice.
Medication choice involves balancing potential benefits, adverse effects, interactions, previous response and individual circumstances. Possible adverse effects vary by drug but can include gastrointestinal symptoms, sleep changes, sexual dysfunction, agitation, headache and other effects. Some people experience little or no benefit from a particular medication and may require a dose adjustment, a different medication or another treatment strategy. Antidepressants can also affect people differently, and younger people require appropriate monitoring for changes in suicidal thinking or behaviour, particularly early in treatment or after dose changes. Clinical supervision is important when starting or changing medication.
Moderate-to-severe depression may benefit from combined psychological and pharmacological treatment, although not everyone needs both. NICE guidance provides treatment pathways based on severity and includes recommendations for antidepressants, psychological therapies and combinations of treatments. (nice.org.uk) Treatment can also involve practical support for housing, employment, relationships, finances or social isolation when these factors are contributing to the persistence of symptoms. Such support is not a replacement for clinical treatment when depression is severe, but addressing major stressors can make recovery more achievable.
Physical activity has evidence for reducing depressive symptoms and can form part of a broader treatment plan, particularly when appropriately prescribed for the person's health and fitness. Regular sleep routines, adequate nutrition, reduced alcohol consumption and avoidance of recreational drugs can also support recovery. These measures should not be presented as cures for clinical depression or as substitutes for professional care in moderate or severe illness. Exercise can be difficult to initiate when depression causes severe fatigue and loss of motivation, so recommendations should be realistic and progressively adapted rather than framed as a test of willpower.
Severe or treatment-resistant depression may require specialist treatment. Depending on the clinical circumstances, options can include more intensive psychological treatment, medication strategies involving specialist review, electroconvulsive therapy and other specialist interventions. Electroconvulsive therapy can be particularly important when depression is severe, life-threatening, associated with psychotic features or requires a relatively rapid response. Treatment-resistant depression generally means inadequate response to appropriate trials of treatment rather than simply having tried one antidepressant. Specialist assessment is important because the causes of apparent treatment resistance can include incorrect diagnosis, inadequate treatment duration, non-adherence, untreated comorbidity and ongoing psychosocial stressors.
Recovery should be monitored rather than judged solely by whether the person feels better on one particular day. Clinicians may monitor symptom severity, functioning, side effects, suicidal thinking and adherence over time. Relapse prevention can include continuing treatment for an appropriate period after improvement, recognising early warning signs and establishing a plan for future episodes when recurrence risk is significant. Depression is treatable, but no single treatment works for everyone. The most appropriate approach is individualised according to diagnosis, severity, risk, preferences, previous response and available evidence.
